Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502580118

TARGETMOL CHEMICALS INC CORILAGIN 25MG
SDP

Catalog No. 502580118
Encompass_Preferred

Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Corilagin has anti-inflammatory activity. Corilagin has a significant antitumour potential and lower toxicity in normal cells in vitro.Corilagin can enhance the cytotoxicity of both cisplatin and doxorubicin on the Hep3B hepatoma cells.Corilagin has antiviral activity reduces the cytotoxicity induced by EV71 or CA16 on Vero cells with and IC50 value of 5.6 and 32.33 ug/mL respectively. Corilagin shows the potential to protect against HSV-1-induced encephalitis and the beneficial effects may be mediated by inhibiting TLR2 signaling pathways.Corilagin has antifibrotics property and is potentiated in treating idiopathic pulmonary fibrosis(IPF) attenuates bleomycin-induced epithelial injury and fibrosis via inactivation of oxidative stress proinflammatory cytokine release and NF-(kappa)B and TGF-(beta)1 signaling. SolventPyridine Methanol Ethanol etc. purity: 99%

Catalog No. 50-258-0118 Supplier TARGETMOL CHEMICALS INC Supplier No. T379525MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Corilagin has anti-inflammatory activity. Corilagin has a significant antitumour potential and lower toxicity in normal cells in vitro.Corilagin can enhance the cytotoxicity of both cisplatin and doxorubicin on the Hep3B hepatoma cells.Corilagin has antiviral activity reduces the cytotoxicity induced by EV71 or CA16 on Vero cells with and IC50 value of 5.6 and 32.33 ug/mL respectively. Corilagin shows the potential to protect against HSV-1-induced encephalitis and the beneficial effects may be mediated by inhibiting TLR2 signaling pathways.Corilagin has antifibrotics property and is potentiated in treating idiopathic pulmonary fibrosis(IPF) attenuates bleomycin-induced epithelial injury and fibrosis via inactivation of oxidative stress proinflammatory cytokine release and NF-(kappa)B and TGF-(beta)1 signaling. SolventPyridine Methanol Ethanol etc. purity: 99%

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.